Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

about

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

Item

http://www.wikidata.org/entity/Q48507362

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@en

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@nl

type

Item

label

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@en

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@nl

prefLabel

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@en

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@nl

P1476

Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

@en

P2093

Jin Woo Choi

http://www.w3.org/2001/XMLSchema#string

Mi Ran Byun

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cell cycles

Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians.

Ovarian cancer: strategies for overcoming resistance to chemotherapy.

Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.

Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration.

Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease.

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation.

Different strategies to overcome multidrug resistance in cancer.

P304

1041-1047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23133

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416675

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5787417

http://www.w3.org/2001/XMLSchema#string